Lev Pharmaceuticals Announces Cinryze(TM) Complete Response Submission Accepted For Review By FDA (Medical News Today)
Lev Pharmaceuticals, Inc. (OTCBB: LEVP.OB) announced that the U.S. Food and Drug Administration (FDA) has accepted for review Lev's complete response submission for Cinryze (C1 inhibitor), the Company's lead product candidate.

Boston Scientific Announces FDA Approval Of New Family Of Advanced Pacemakers (Medical News Today)
Boston Scientific Corporation (NYSE: BSX) announced U.S. Food and Drug Administration (FDA) approval of its ALTRUA(TM) family of pacemakers. ALTRUA is Boston Scientific's most advanced pacemaker and delivers enhanced therapies while maintaining its small size and battery longevity.

St. Jude Medical Announces FDA Clearance And CE Mark Approval Of Strada Carotid Guiding Sheath (Medical News Today)
St. Jude Medical, Inc. (NYSE:STJ) announced U.S. Food and Drug Administration (FDA) clearance and European CE Mark approval of the Strada Carotid Guiding Sheath, a flexible tube through which physicians can deliver balloon catheters, stents and other tools to open blockages in the carotid arteries.